Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Copper(II) Complexes Containing Natural Flavonoid Pomiferin Show Considerable in Vitro Cytotoxicity and Anti-Inflammatory Effects

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F21%3A73609060" target="_blank" >RIV/61989592:15310/21:73609060 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/61989592:15640/21:73609060

  • Výsledek na webu

    <a href="https://www.mdpi.com/1422-0067/22/14/7626" target="_blank" >https://www.mdpi.com/1422-0067/22/14/7626</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3390/ijms22147626" target="_blank" >10.3390/ijms22147626</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Copper(II) Complexes Containing Natural Flavonoid Pomiferin Show Considerable in Vitro Cytotoxicity and Anti-Inflammatory Effects

  • Popis výsledku v původním jazyce

    A series of new heteroleptic copper(II) complexes of the composition [Cu(L)(bpy)]NO3 center dot 2MeOH (1), [Cu(L)(dimebpy)]NO3 center dot 2H(2)O (2), [Cu(L)(phen)]NO3 center dot 2MeOH (3), [Cu(L)(bphen)]NO3 center dot MeOH (4), [Cu(L)(dppz)]NO3 center dot MeOH (5) was prepared, where HL = 3-(3,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-6-(3-methylbut-2-ene-1-yl)-4H,8H-benzo[1,2-b:3,4-b &apos;]dipyran-4-one, (pomiferin) and bpy = 2,2 &apos;-bipyridine, dimebpy = 4,4 &apos;-dimethyl-2,2 &apos;-bipyridine, phen = 1,10-phenanthroline, bphen = 4,7-diphenyl-1,10-phenanthroline, and dppz = dipyrido[3,2-a:2 &apos;,3 &apos;-c]phenazine. The complexes were characterized using elemental analysis, infrared and UV/Vis spectroscopies, mass spectrometry, thermal analysis and conductivity measurements. The in vitro cytotoxicity, screened against eight human cancer cell lines (breast adenocarcinoma (MCF-7), osteosarcoma (HOS), lung adenocarcinoma (A549), prostate adenocarcinoma (PC-3), ovarian carcinoma (A2780), cisplatin-resistant ovarian carcinoma (A2780R), colorectal adenocarcinoma (Caco-2) and monocytic leukemia (THP-1), revealed the complexes as effective antiproliferative agents, with the IC50 values of 2.2-13.0 mu M for the best performing complexes 3 and 5. All the complexes 1-5 showed the best activity against the A2780R cells (IC50 = 2.2-6.6 mu M), and moreover, the complexes demonstrated relatively low toxicity on healthy human hepatocytes, with IC50 &gt; 100 mu M. The complexes were evaluated by the Annexin V/propidium iodide apoptosis assay, induction of cell cycle modifications in A2780 cells, production of reactive oxygen species (ROS), perturbation of mitochondrial membrane potential, inhibition of apoptosis and inflammation-related signaling pathways (NF-kappa B/AP-1 activity, NF-kappa B translocation, TNF-alpha secretion), and tested for nuclease mimicking activity. The obtained results revealed the corresponding complexes to be effective antiproliferative and anti-inflammatory agents.

  • Název v anglickém jazyce

    Copper(II) Complexes Containing Natural Flavonoid Pomiferin Show Considerable in Vitro Cytotoxicity and Anti-Inflammatory Effects

  • Popis výsledku anglicky

    A series of new heteroleptic copper(II) complexes of the composition [Cu(L)(bpy)]NO3 center dot 2MeOH (1), [Cu(L)(dimebpy)]NO3 center dot 2H(2)O (2), [Cu(L)(phen)]NO3 center dot 2MeOH (3), [Cu(L)(bphen)]NO3 center dot MeOH (4), [Cu(L)(dppz)]NO3 center dot MeOH (5) was prepared, where HL = 3-(3,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-6-(3-methylbut-2-ene-1-yl)-4H,8H-benzo[1,2-b:3,4-b &apos;]dipyran-4-one, (pomiferin) and bpy = 2,2 &apos;-bipyridine, dimebpy = 4,4 &apos;-dimethyl-2,2 &apos;-bipyridine, phen = 1,10-phenanthroline, bphen = 4,7-diphenyl-1,10-phenanthroline, and dppz = dipyrido[3,2-a:2 &apos;,3 &apos;-c]phenazine. The complexes were characterized using elemental analysis, infrared and UV/Vis spectroscopies, mass spectrometry, thermal analysis and conductivity measurements. The in vitro cytotoxicity, screened against eight human cancer cell lines (breast adenocarcinoma (MCF-7), osteosarcoma (HOS), lung adenocarcinoma (A549), prostate adenocarcinoma (PC-3), ovarian carcinoma (A2780), cisplatin-resistant ovarian carcinoma (A2780R), colorectal adenocarcinoma (Caco-2) and monocytic leukemia (THP-1), revealed the complexes as effective antiproliferative agents, with the IC50 values of 2.2-13.0 mu M for the best performing complexes 3 and 5. All the complexes 1-5 showed the best activity against the A2780R cells (IC50 = 2.2-6.6 mu M), and moreover, the complexes demonstrated relatively low toxicity on healthy human hepatocytes, with IC50 &gt; 100 mu M. The complexes were evaluated by the Annexin V/propidium iodide apoptosis assay, induction of cell cycle modifications in A2780 cells, production of reactive oxygen species (ROS), perturbation of mitochondrial membrane potential, inhibition of apoptosis and inflammation-related signaling pathways (NF-kappa B/AP-1 activity, NF-kappa B translocation, TNF-alpha secretion), and tested for nuclease mimicking activity. The obtained results revealed the corresponding complexes to be effective antiproliferative and anti-inflammatory agents.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    10402 - Inorganic and nuclear chemistry

Návaznosti výsledku

  • Projekt

    Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

  • Návaznosti

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Ostatní

  • Rok uplatnění

    2021

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

  • ISSN

    1422-0067

  • e-ISSN

  • Svazek periodika

    22

  • Číslo periodika v rámci svazku

    14

  • Stát vydavatele periodika

    CH - Švýcarská konfederace

  • Počet stran výsledku

    29

  • Strana od-do

  • Kód UT WoS článku

    000676291100001

  • EID výsledku v databázi Scopus

    2-s2.0-85110138617